BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

61.46

+1.55 (2.59%)

At close: Aug 6, 2026, 4:00 PM EDT

64.55

+3.09 (5.03%)

After-hours: Aug 6, 2026, 7:45 PM EDT

BioMarin Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	72.97	348.9	426.86	167.65	141.56	-64.08
Depreciation & Amortization	152.97	79.56	96.43	104.39	101.97	108.04
Stock-Based Compensation	215.33	181.41	201.57	207.1	196.31	197.26
Other Adjustments	133.96	511.79	64.38	16.67	-167.55	-2.72
Change in Receivables	-117.94	-228.05	-57.91	-190.44	-82.03	65.57
Changes in Inventories	-32.13	-116.93	-63.53	-157.06	-68.26	-35.06
Changes in Accounts Payable	89.29	66.14	-32.24	68.85	59.02	15.69
Changes in Other Operating Activities	0.33	-14.81	-62.72	-57.9	-5.1	19.83
Operating Cash Flow	857.09	827.99	572.84	159.26	175.9	304.54
Operating Cash Flow Growth	11.78%	44.54%	259.69%	-9.46%	-42.24%	256.75%
Capital Expenditures	-118.91	-103.04	-85.42	-96.69	-120.96	-95.58
Sale of Property, Plant & Equipment	-	-	10	-	103.33	-
Purchases of Intangible Assets	-13.1	-7.94	-11.99	-10.92	-10.58	-23.65
Purchases of Investments	-179.23	-355.88	-410.25	-868.5	-611.81	-937.14
Proceeds from Sale of Investments	909.34	337.8	633.02	864.86	620	691.05
Cash Acquisitions	-	-285.19	-	-	-	-
Other Investing Activities	6.11	1.14	-	-	-	-0.99
Investing Cash Flow	-4,750	-414.24	136.49	-111.24	-20.03	-366.31
Long-Term Debt Issued	3,650	-	-	-	-	-
Long-Term Debt Repaid	-	-	-494.99	-	-	-
Net Long-Term Debt Issued (Repaid)	3,650	-	-494.99	-	-	-
Issuance of Common Stock	13.41	14.46	49.28	69.35	69.33	49.19
Repurchase of Common Stock	-44.38	-55.97	-77.56	-76.32	-54.28	-45.81
Net Common Stock Issued (Repurchased)	-30.97	-41.51	-28.28	-6.97	15.05	3.39
Other Financing Activities	-65.6	-0.89	-3.18	-11.76	-33.7	-3.44
Financing Cash Flow	3,553	-42.39	-526.45	-18.73	-18.65	-0.05
Foreign Exchange Rate Adjustments	0.33	-2.52	4.83	1.31	0.03	-0.06
Net Cash Flow	-339.81	368.84	187.72	30.6	137.26	-61.88
Free Cash Flow	738.18	724.96	487.42	62.57	54.94	208.96
Free Cash Flow Growth	6.23%	48.73%	679.02%	13.88%	-73.71%	-
FCF Margin	21.67%	22.51%	17.08%	2.59%	2.62%	11.32%
Free Cash Flow Per Share	3.80	3.67	2.48	0.33	0.29	1.14
Levered Free Cash Flow	3,815	259.81	-215.61	29.24	108.22	-51.16
Unlevered Free Cash Flow	164.6	207.02	234.03	26.76	119.01	-57.1

SEC Filings: 10-K · 10-Q